CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

Reporting of anosmia, ageusia and other clinical symptomsWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)

Name (Synonyms) Correlation

Correlated MeSH Terms (1)

Name (Synonyms) Correlation
D004194 Disease NIH 0.18

Correlated HPO Terms (0)

Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials

1 Diagnostic Value of Patient - Reported and Clinically Verified Olfactory Disorders in a Population Tested for COVID-19

Participants are healthcare workers and adult outpatients referred in a COVID-19 screening center. Patients-reported symptoms are collected, then participants underwent a simple olfactory test (CODA for Clinical Olfactory Dysfunction Assessment), prior to swabbing for SARS-CoV-2 diagnosis (RT-PCR). We aimed to evaluate the prevalence of smell and taste disorders, and to calculate the diagnostic value of patient-reported and clinically verified smell disorders in persons with suspected COVID-19.

NCT04407494 COVID-19 Biological: Reporting of anosmia, ageusia and other clinical symptoms
MeSH:Disease

Primary Outcomes

Description: Diagnostic values of anosmia and ageusia for COVID-19 with questionnaire

Measure: Diagnostic values of anosmia and ageusia for COVID-19

Time: at inclusion

Secondary Outcomes

Description: Diagnostic values of CODA (Clinical Olfactory dysfunction Assessment) score for COVID-19 : Simple, fast, semi-objective olfactory test developed for epidemic context

Measure: Diagnostic values of CODA

Time: at inclusion

No related HPO nodes (Using clinical trials)